| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.7M | -57.7% | — |
| Cost of Revenue | $329K | -58.3% | — |
| Gross Profit | $1.3M | -57.6% | — |
| R&D Expense | $1.6M | +2.1% | -56.6% |
| SG&A Expense | $26.4M | +361.3% | +450.7% |
| Operating Income | -$32.2M | -257.0% | -185.9% |
| Interest Expense | $79K | +72.1% | — |
| Pre-tax Income | -$28.3M | -210.4% | -152.0% |
| Income Tax | -$231K | -187.5% | -187.5% |
| Net Income | -$28.1M | -199.2% | -144.2% |
| EPS (Basic) | -$0.95 | -150.0% | +25.2% |
| EPS (Diluted) | -$0.95 | -150.0% | +25.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.6M | -40.6% | — |
| Accounts Receivable | $1.1M | -73.4% | — |
| Inventory | $22.7M | +0.1% | +47.7% |
| Current Assets | $31.7M | -16.5% | +72.4% |
| Total Assets | $132.5M | -5.6% | +9.1% |
| Current Liabilities | $55.0M | +44.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$14.3M | -10.0% | — |
| Investing Cash Flow | -$5.0M | -13.6% | — |
| Financing Cash Flow | $19.6M | -5.9% | — |
| +10.3% |
| Total Liabilities | $63.5M | +35.2% | +9.6% |
| Stockholders' Equity | $61.5M | -23.0% | +1.5% |